Pasritamig
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Pasritamig, covering 2026-04-13 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 3]